IP Library Patent Application 15266787
Patent Application
App. No. 15/266,787

APPLICATIONS OF SINGLE MOLECULE SEQUENCING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/266,787
Abstract

The invention provides methods for determining the presence of a disease by comparing a sequence from a single target molecule with a predetermined sequence that is associated with a specific disease.

Claims (19)

1 . A method for detecting low abundance nucleic acids indicative of a disease state in a heterogeneous sample, the method comprising the steps of:

a) obtaining a biological sample suspected to contain a nucleic acid that would not be expected to be present in the sample if the individual from whom it was obtained were healthy;

b) conducting a sequencing reaction on nucleic acid in said sample; and

c) comparing nucleic acid sequences obtained in said conducting step to one or more reference sequences that represent nucleic acids that are not expected to be present in a sample obtained from a healthy individual, thereby to identify nucleic acids in said sample that are indicative of a disease state.

2 . The method of claim 1 , wherein said biological sample is blood or another body fluid.

3 . The method of claim 1 , wherein said biological sample is obtained from tissue.

4 . The method of claim 1 , wherein said reference sequences represent a mutation that is indicative of cancer or precancer.

5 . The method of claim 1 , wherein said reference sequences represent an infectious disease agent.

6 . The method of claim 1 , wherein said heterogeneous sample comprises nucleic acid derived from multiple cell types.

7 . The method of claim 4 , wherein said mutation is a mutation or a deletion.

8 . The method of claim 1 , wherein said biological sample is maternal blood.

9 . The method of claim 8 , wherein said reference nucleic acid is fetal DNA or RNA.

10 . The method of claim 1 , wherein said comparing step identifies the presence of nucleic acids derived from multiple organisms in a pooled sample.

11 . A method for detecting a nucleic acid sequence in a heterogeneous sample, wherein said sample is suspected to contain a nucleic acid template that would not be expected to be present in said sample, the method comprising the steps of:

a) obtaining a heterogeneous sample, comprising a nucleic acid;

b) depositing said sample onto a substrate;

c) conducting a template dependent primer extension reaction on said sample, thereby obtaining sequence information for said heterogeneous sample; and

d) comparing a sequence obtained in said conducting step to a reference sequence, thereby detecting said nucleic acid template that would not be expected to be present in said sample.

12 . The method of claim 11 , wherein the sample is deposited onto the substrate such that at least a portion of nucleic acids contained in said sample are individually optically resolvable on said substrate.

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 16, 2016
From: CALIFORNIA INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039761/0538 →